FiercePharma

Amgen's romosozumab red flag on heart safety means a boost for new Radius bone drug

When Radius Health scored an early approval for its osteoporosis med Tymlos last month, industry watchers thought it wouldn't be long before the drug had to contend with another newcomer from Amgen.
Healio

Bone mineral density gains from Tymlos for osteoporosis maintained following alendronate

Please provide your email address to receive an email when new articles are posted on . Gains in ultradistal radius bone mineral density demonstrated by postmenopausal women with osteoporosis who had ...
FierceBiotech

Radius Health Presents Positive Phase 3 Top-Line Data for Investigational Osteoporosis Therapy Abaloparatide at the American Society for Bone and Mineral Research 2015 Annual ...

WALTHAM, Mass., Oct. 10, 2015 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announces positive top-line data from the Phase 3 ACTIVE (Abaloparatide Comparator Trial In Vertebral Endpoints) ...
Medscape

A Customized Protocol to Assess Bone Quality in the Metacarpal Head, Metacarpal Shaft and Distal Radius

This study extends the literature that uses in HR pQCT to examine ''bone quality" in vivo in a novel way using customized image acquisition and analyses protocols to assess bone parameters in the ...